31 Jan 2023
// GLOBENEWSWIRE
25 Oct 2022
// GLOBENEWSWIRE
30 Sep 2022
// CPHI-ONLINE
Latest Content by PharmaCompass
01 2ONDANSETRON
01 2TABLET (ORALLY DISINTEGRATING)
01 14MG
02 18MG
01 2ATHENA-ONDANSETRON ODT
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 4MG
Packaging :
Brand Name : ATHENA-ONDANSETRON ODT
Approval Date :
Application Number : 2444674
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Dosage Strength : 8MG
Packaging :
Brand Name : ATHENA-ONDANSETRON ODT
Approval Date :
Application Number : 2444682
Regulatory Info : Prescription
Registration Country : Canada
LOOKING FOR A SUPPLIER?